Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model

References

• Magliano DJ, Chen L, Islam RM, et al. Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings. Lancet Diabetes Endocrinol. 2021;9(4):203–211. doi:10.1016/S2213-8587(20)30402-2
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Alwin Robert A, Abdulaziz Al Dawish M, Braham R, Ali Musallam M, Abdullah Al Hayek A, Hazza Al Kahtany N. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Current Diabetes Rev. 2017;13(1):59–64. doi:10.2174/1573399812666160126142605
   PubMedGoogle Scholar
• Al-Jedai AH, Almudaiheem HY, Alissa DA, et al. Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: a retrospective analysis of claims database. PLoS One. 2022;17(10):e0273836. doi:10.1371/journal.pone.0273836
   PubMed Web of Science ®Google Scholar
• Chapman D, Foxcroft R, Dale-Harris L, et al. Insights for care: the healthcare utilisation and cost impact of managing type 2 diabetes-associated microvascular complications. Diabetes Ther. 2019;10(2):575–585. doi:10.1007/s13300-018-0548-4
   PubMed Web of Science ®Google Scholar
• Alramadan MJ, Magliano DJ, Alhamrani HA, et al. Lifestyle factors and macro-and micro-vascular complications among people with type 2 diabetes in Saudi Arabia. Diabetes Metabol Syndr. 2019;13(1):484–491. doi:10.1016/j.dsx.2018.11.007
   PubMed Web of Science ®Google Scholar
• Alotaibi YK, Al-Nowaiser N, Al Harbi TJ, Tourkmani AM, Moharram M. Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021. BMJ Open Qual. 2023;12(2):e002037. doi:10.1136/bmjoq-2022-002037
   PubMedGoogle Scholar
• Alhowaish AK. Economic costs of diabetes in Saudi Arabia. J Fam Community Med. 2013;20(1):1. doi:10.4103/2230-8229.108174
   PubMedGoogle Scholar
• Iglay K, Hannachi H, Joseph Howie P, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243–1252. doi:10.1185/03007995.2016.1168291
   PubMed Web of Science ®Google Scholar
• Singh K, Kondal D, Menon VU, et al. Cost-effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: the CARRS randomized clinical trial. Diabetic Med. 2023;40(9):e15074. doi:10.1111/dme.15074
   PubMed Web of Science ®Google Scholar
• Visaria J, Iyer NN, Raval AD, et al. Healthcare costs of diabetes and microvascular and macrovascular disease in individuals with incident type 2 diabetes mellitus: a ten-year longitudinal study. Clinicoecon Outcomes Res. 2020;12:423–434. doi:10.2147/CEOR.S247498
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405
   PubMed Web of Science ®Google Scholar
• Zhao H, Shu L, Huang W, Wang W, Song G. Difference analysis of related factors in macrovascular and microvascular complications in Chinese patients with Type 2 diabetes mellitus: a case-control study protocol. Diabetes Metabol Syndr Obes. 2019;12:2193–2200. doi:10.2147/DMSO.S213848
   PubMed Web of Science ®Google Scholar
• Akın S, Bölük C. Prevalence of comorbidities in patients with type–2 diabetes mellitus. Prim Care Diabetes. 2020;14(5):431–434. doi:10.1016/j.pcd.2019.12.006
   PubMed Web of Science ®Google Scholar
• Jendle J, Ericsson Å, Hunt B, Valentine WJ, Pollock RF. Achieving good glycemic control early after onset of diabetes: a cost-effectiveness analysis in patients with type 1 diabetes in Sweden. Diabetes Ther. 2018;9(1):87–99. doi:10.1007/s13300-017-0344-6
   PubMed Web of Science ®Google Scholar
• Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovas Diabetol. 2021;20(1):1–13. doi:10.1186/s12933-020-01200-7
   PubMed Web of Science ®Google Scholar
• Ellahham S. Diabetes and its associated cardiovascular complications in the Arabian Gulf: challenges and Opportunities. J Clin Exp Cardiolog. 2020;11(1):1–5.
   Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–928. doi:10.2337/dci18-0007
   PubMed Web of Science ®Google Scholar
• Hudon C, Chouinard MC, Diadiou F, Lambert M, Bouliane D. Case management in primary care for frequent users of health care services with chronic diseases: a qualitative study of patient and family experience. Ann Fam Med. 2015;13(6):523–528. doi:10.1370/afm.1867
   PubMed Web of Science ®Google Scholar
• Alramadan MJ, Magliano DJ, Almigbal TH, et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia-an urgent need for a review of management plan. BMC Endocr Disord. 2018;18(1):62. doi:10.1186/s12902-018-0292-9
   PubMedGoogle Scholar
• van Wier MF, Lakerveld J, Bot SD, Chinapaw MJ, Nijpels G, van Tulder MW. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial. BMC Fam Pract. 2013;14(1):1–10. doi:10.1186/1471-2296-14-45
   PubMedGoogle Scholar
• Alshowair A, Altamimi S, Alshahrani S, et al. Effectiveness of case manager led multi-disciplinary team approach on glycemic control amongst T2DM patients in primary care in Riyadh: a retrospective follow-up study. J Prim Care Community Health. 2023;14:1–8. doi:10.1177/21501319231204592
   Web of Science ®Google Scholar
• Tourkmani AM, Abdelhay O, Alkhashan HI, et al. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study. BMC Fam Pract. 2018;19(1):1. doi:10.1186/s12875-017-0677-2
   PubMedGoogle Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin. 2004;20(sup1):S5–S26. doi:10.1185/030079904X1980
   PubMed Web of Science ®Google Scholar
• Tashtish N, Al-Kindi SG, Oliveira GH, Robinson MR. Length of stay and hospital charges for heart failure admissions in the United States: analysis of the national inpatient sample. J Card Fail. 2017;23(8):S59. doi:10.1016/j.cardfail.2017.07.166
   Web of Science ®Google Scholar
• Lu Q, Wang J, Wei X, et al. Cost of diabetic foot ulcer management in China: a 7-year single-center retrospective review. Diabetes Metabol Syndr Obes. 2020;13:4249. doi:10.2147/DMSO.S275814
   PubMed Web of Science ®Google Scholar
• Budiman-Mak E, Epstein N, Brennan M, et al. Systolic blood pressure variability and lower extremity amputation in a non-elderly population with diabetes. Diabetes Res Clin Pract. 2016;114:75–82. doi:10.1016/j.diabres.2016.01.010
   PubMed Web of Science ®Google Scholar
• Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019;10(3):140. doi:10.4239/wjd.v10.i3.140
   PubMed Web of Science ®Google Scholar
• Samya V, Shriraam V, Jasmine A, et al. Prevalence of hypoglycemia among patients with type 2 diabetes mellitus in a rural health center in South India. J Prim Care Community Health. 2019;10:2150132719880638. doi:10.1177/2150132719880638
   Web of Science ®Google Scholar
• Alsaigh SH, Alzaghran RH, Alahmari DA, Hameed LN, Alfurayh KM, Alaql KB. Knowledge, awareness, and practice related to diabetic foot ulcer among healthcare workers and diabetic patients and their relatives in Saudi Arabia: a cross-sectional study. Cureus. 2022;14(12). doi:10.7759/cureus.32221
   Web of Science ®Google Scholar
• Walicka M, Raczyńska M, Marcinkowska K, et al. Amputations of lower limb in subjects with diabetes mellitus: reasons and 30-day mortality. J Diabetes Res. 2021;2021:1–8. doi:10.1155/2021/8866126
   Web of Science ®Google Scholar
• Al-Thani H, Sathian B, El-Menyar A. Assessment of healthcare costs of amputation and prosthesis for upper and lower extremities in a Qatari healthcare institution: a retrospective cohort study. BMJ open. 2019;9(1):e024963. doi:10.1136/bmjopen-2018-024963
   PubMed Web of Science ®Google Scholar
• Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–419. doi:10.1136/bmj.321.7258.412
   PubMed Web of Science ®Google Scholar
• Morales J, Schneider D. Hypoglycemia. Am j Med. 2014;127(10):S17–S24. doi:10.1016/j.amjmed.2014.07.004
   PubMed Web of Science ®Google Scholar
• Ni Y, Liu S, Li J, et al. The effects of nurse-led multidisciplinary team management on glycosylated hemoglobin, quality of life, hospitalization, and help-seeking behavior of people with diabetes mellitus. J Diabetes Res. 2019;9. doi:10.1155/2019/9325146
   Google Scholar
• Celano CM, Gianangelo TA, Millstein RA, et al. A positive psychology-motivational interviewing intervention for patients with type 2 diabetes: proof-of-concept trial. Int J Psychiatry Med. 2019;54(2):97–114. doi:10.1177/0091217418791448
   PubMed Web of Science ®Google Scholar
• Ismail K, Winkley K, de Zoysa N, et al. Nurse-led psychological intervention for type 2 diabetes: a cluster randomised controlled trial (Diabetes-6 study) in primary care. Br J Gen Pract. 2018;68(673):531–540. doi:10.3399/bjgp18X696185
   PubMed Web of Science ®Google Scholar
• Wan EYF, Fung CSC, Jiao FF, et al. Five-year effectiveness of the multidisciplinary risk assessment and management programme diabetes mellitus (RAMP-DM) on diabetes-related complications and health service uses-a population-based and propensity-matched cohort study. Diabetes Care. 2018;41(1):49–59. doi:10.2337/dc17-0426
   PubMed Web of Science ®Google Scholar
• Singh K, Narayan KMV, Eggleston K. Economic impact of diabetes in South Asia: the magnitude of the problem. Curr Diab Rep. 2019;19(6):34. doi:10.1007/s11892-019-1146-1
   PubMed Web of Science ®Google Scholar
• Siegel KR, Ali MK, Zhou X, et al. Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008? Diabetes Care. 2020;43(7):1557–1592. doi:10.2337/dci20-0017
   PubMed Web of Science ®Google Scholar
• Afroz A, Chowdhury HA, Shahjahan M, Hafez MA, Hassan MN, Ali L. Association of good glycemic control and cost of diabetes care: experience from a tertiary care hospital in Bangladesh. Diabetes Res Clin Pract. 2016;120:142–148. doi:10.1016/j.diabres.2016.07.030
   PubMed Web of Science ®Google Scholar
• Egede LE, Walker RJ, Dismuke-Greer CE, et al. Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: a pilot randomized controlled trial. PLoS One. 2021;16(3):e0248762. doi:10.1371/journal.pone.0248762
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chaudhari P, Yang H, et al. Healthcare resource use, costs, and disease progression associated with diabetic nephropathy in adults with type 2 diabetes: a retrospective observational study. Diabetes Ther. 2017;8(3):555–571. doi:10.1007/s13300-017-0256-5
   PubMed Web of Science ®Google Scholar
• Owolabi LF, Alghamdi M, Adamu B, et al. Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis. BMC Endocr Disord. 2022;22(1):1–12. doi:10.1186/s12902-022-01167-4
   PubMed Web of Science ®Google Scholar
• Sadosky A, Mardekian J, Parsons B, Hopps M, Bienen EJ, Markman J. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. J Diabetes Complications. 2015;29(2):212–217. doi:10.1016/j.jdiacomp.2014.10.013
   PubMed Web of Science ®Google Scholar
• Al-Ozairi E, Jallo MK, Hafidh K, et al. Prevalence of cardiovascular and renal co-morbidities in patients with type 2 diabetes in the gulf, a cross-sectional observational study. Diabetes Ther. 2021;12(4):1193–1207. doi:10.1007/s13300-021-01038-6
   PubMed Web of Science ®Google Scholar
• Annavarapu S, Ghosh S, Li Y, Moretz C, Shetty S, Prewitt T. Healthcare resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations. Am J Manag Care. 2020;26(6):e166–e171.
   PubMed Web of Science ®Google Scholar
• Artime E, Romera I, Diaz-Cerezo S, Delgado E. Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: a Systematic Review. Diabetes Ther. 2021;12(6):1631–1659. doi:10.1007/s13300-021-01060-8
   PubMed Web of Science ®Google Scholar